Page 10 - Dcph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teacher Retirement System of Texas purchased a new stake in shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) during the 3rd quarter, HoldingsChannel reports. The firm purchased 12,935 shares of the company’s stock, valued at approximately $239,000. Other hedge funds and other institutional investors have also added to or reduced their stakes in the […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities researchers at SVB Leerink reduced their FY2026 earnings per share estimates for Deciphera Pharmaceuticals in a note issued to investors on Wednesday, January 4th. SVB Leerink analyst A. Berens now expects that the company will earn $3.38 per share for the year, down from their previous […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) insider Jama Pitman sold 1,298 shares of the company’s stock in a transaction dated Thursday, June 16th. The shares were sold at an average price of $10.75, for a total transaction of $13,953.50. Following the completion of the transaction, the insider now directly owns 36,661 shares in the […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) EVP Matthew L. Sherman sold 1,768 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Thursday, June 16th. The shares were sold at an average price of $10.75, for a total transaction of $19,006.00. Following the sale, the executive vice president now owns 76,884 shares of […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities researchers at Jefferies Financial Group lifted their Q2 2022 earnings estimates for Deciphera Pharmaceuticals in a research report issued on Wednesday, May 4th. Jefferies Financial Group analyst E. Yang now expects that the company will post earnings of ($0.70) per share for the quarter, up from […]